Literature DB >> 12856125

Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats.

F Saito1, M Kawaguchi, J Izumida, T Asakura, K Maehara, Y Maruyama.   

Abstract

AIMS/HYPOTHESIS: The process of cardiovascular complications in Type 2 diabetes mellitus (DM) is unclear. We investigated pathophysiological changes of the heart and vessels in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat Type 2 DM model during a long time period.
METHODS: Echocardiography was carried out at 22 and 62 weeks of age of OLETF ( n=10, each) and age-matched Long-Evans Tokushima Otsuka (LETO) rats ( n=10, each) as a reference. Haemodynamic measurements and histological examinations of the heart and the coronary and aortic vascular walls were done.
RESULTS: The left ventricular (LV) maximal -dP/dt was reduced in OLETF rats at 62 weeks (-1085+/-35 mmHg/s) less than that at 22 weeks (-1892+/-396 mmHg/sec, p<0.05) and in LETO rats at 62 weeks (-1306+/-200 mmHg/sec, p<0.05). Wall thickening of intramyocardial coronary arteries, capillary tortuosity and thickening of basement membrane were evident in OLETF rats at 62 weeks. Intimal and medial wall thickening of the aorta were prominent in OLETF rats at 62 weeks (15+/-2.2 and 90+/-6.6 micro m, in LETO rats at 62 weeks, 2+/-0.4 and 65+/-5.2 micro m, p <0.05, and in OLETF rats at 22 weeks, 7+/-4.6 and 71+/-6.0 micro m, p<0.05, respectively). CONCLUSIONS/
INTERPRETATION: In the Type 2 DM model, angiopathy, especially in coronary arteries including small vessels, as well as a LV relaxation abnormality, are induced in a late stage of DM. These are considered to be important complications in Type 2 DM.

Entities:  

Mesh:

Year:  2003        PMID: 12856125     DOI: 10.1007/s00125-003-1156-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

Review 2.  Subcellular remodeling and heart dysfunction in chronic diabetes.

Authors:  N S Dhalla; X Liu; V Panagia; N Takeda
Journal:  Cardiovasc Res       Date:  1998-11       Impact factor: 10.787

3.  Relationships between diet control and the development of spontaneous type II diabetes and diabetic nephropathy in OLETF rats.

Authors:  S Mori; K Kawano; T Hirashima; T Natori
Journal:  Diabetes Res Clin Pract       Date:  1996-08       Impact factor: 5.602

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy.

Authors:  S M Factor; T Minase; E H Sonnenblick
Journal:  Am Heart J       Date:  1980-04       Impact factor: 4.749

6.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

7.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

Authors:  K Mizushige; L Yao; T Noma; H Kiyomoto; Y Yu; N Hosomi; K Ohmori; H Matsuo
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

8.  The effect of diabetes on performance and metabolism of rat hearts.

Authors:  S Penpargkul; T Schaible; T Yipintsoi; J Scheuer
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

9.  The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance.

Authors:  R V Vadlamudi; R L Rodgers; J H McNeill
Journal:  Can J Physiol Pharmacol       Date:  1982-07       Impact factor: 2.273

10.  Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.

Authors:  K Numaguchi; K Egashira; M Takemoto; T Kadokami; H Shimokawa; K Sueishi; A Takeshita
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

View more
  14 in total

1.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

Review 2.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy.

Authors:  Aki Okamoto; Yasuhiko Iwamoto; Yoshiro Maru
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation.

Authors:  Kooresh I Shoghi; Robert J Gropler; Terry Sharp; Pilar Herrero; Nicole Fettig; Yi Su; Mayurranjan S Mitra; Attila Kovacs; Brian N Finck; Michael J Welch
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

Review 5.  Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review.

Authors:  Ernest Adeghate
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

6.  Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway.

Authors:  Young-Hee Kim; Yoon-Sook Kim; Chang-Hwan Park; In-Yong Chung; Ji-Myong Yoo; Jae-Geun Kim; Byung-Ju Lee; Sang-Soo Kang; Gyeong-Jae Cho; Wan-Sung Choi
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

7.  Alteration of Vascular Responsiveness to Uridine Adenosine Tetraphosphate in Aortas Isolated from Male Diabetic Otsuka Long-Evans Tokushima Fatty Rats: The Involvement of Prostanoids.

Authors:  Takayuki Matsumoto; Shota Kobayashi; Makoto Ando; Maika Iguchi; Keisuke Takayanagi; Mihoka Kojima; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Int J Mol Sci       Date:  2017-11-09       Impact factor: 5.923

8.  Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics.

Authors:  Qian Cai; Baoying Li; Fei Yu; Weida Lu; Zhen Zhang; Mei Yin; Haiqing Gao
Journal:  J Diabetes Res       Date:  2013-02-25       Impact factor: 4.011

9.  Cardiovascular changes in animal models of metabolic syndrome.

Authors:  Alexandre M Lehnen; Bruno Rodrigues; Maria Cláudia Irigoyen; Kátia De Angelis; Beatriz D'Agord Schaan
Journal:  J Diabetes Res       Date:  2013-03-14       Impact factor: 4.011

10.  Exacerbation of acidosis during ischemia and reperfusion arrhythmia in hearts from type 2 Diabetic Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Ryuko Anzawa; Shingo Seki; Kazuaki Horikoshi; Masayuki Taniguchi; Seibu Mochizuki
Journal:  Cardiovasc Diabetol       Date:  2007-06-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.